These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


142 related items for PubMed ID: 7484080

  • 1. Cerebrospinal neuron-specific enolase, S-100 and myelin basic protein in neurological disorders.
    Lamers KJ, van Engelen BG, Gabreëls FJ, Hommes OR, Borm GF, Wevers RA.
    Acta Neurol Scand; 1995 Sep; 92(3):247-51. PubMed ID: 7484080
    [Abstract] [Full Text] [Related]

  • 2. Age-related changes of neuron-specific enolase, S-100 protein, and myelin basic protein concentrations in cerebrospinal fluid.
    van Engelen BG, Lamers KJ, Gabreels FJ, Wevers RA, van Geel WJ, Borm GF.
    Clin Chem; 1992 Jun; 38(6):813-6. PubMed ID: 1375875
    [Abstract] [Full Text] [Related]

  • 3. Protein S-100B, neuron-specific enolase (NSE), myelin basic protein (MBP) and glial fibrillary acidic protein (GFAP) in cerebrospinal fluid (CSF) and blood of neurological patients.
    Lamers KJ, Vos P, Verbeek MM, Rosmalen F, van Geel WJ, van Engelen BG.
    Brain Res Bull; 2003 Aug 15; 61(3):261-4. PubMed ID: 12909296
    [Abstract] [Full Text] [Related]

  • 4. Neurobiochemical markers of brain damage in cerebrospinal fluid of acute ischemic stroke patients.
    Brouns R, De Vil B, Cras P, De Surgeloose D, Mariën P, De Deyn PP.
    Clin Chem; 2010 Mar 15; 56(3):451-8. PubMed ID: 19959621
    [Abstract] [Full Text] [Related]

  • 5. Prognostic value of cerebrospinal fluid neuron-specific enolase and S-100b protein in Guillain-Barré syndrome.
    Mokuno K, Kiyosawa K, Sugimura K, Yasuda T, Riku S, Murayama T, Yanagi T, Takahashi A, Kato K.
    Acta Neurol Scand; 1994 Jan 15; 89(1):27-30. PubMed ID: 8178624
    [Abstract] [Full Text] [Related]

  • 6. Neuron-specific enolase, S-100 protein, myelin basic protein and lactate in CSF in dementia.
    Nooijen PT, Schoonderwaldt HC, Wevers RA, Hommes OR, Lamers KJ.
    Dement Geriatr Cogn Disord; 1997 Jan 15; 8(3):169-73. PubMed ID: 9137895
    [Abstract] [Full Text] [Related]

  • 7. Neuron-specific Enolase and myelin basic protein in cerebrospinal fluid of patients with first episode schizophrenia.
    Li S, Wu H, Guo H, Zhao Z.
    J Huazhong Univ Sci Technolog Med Sci; 2006 Jan 15; 26(2):228-30. PubMed ID: 16850754
    [Abstract] [Full Text] [Related]

  • 8. Increased cerebrospinal fluid and serum levels of S100B in first-onset schizophrenia are not related to a degenerative release of glial fibrillar acidic protein, myelin basic protein and neurone-specific enolase from glia or neurones.
    Steiner J, Bielau H, Bernstein HG, Bogerts B, Wunderlich MT.
    J Neurol Neurosurg Psychiatry; 2006 Nov 15; 77(11):1284-7. PubMed ID: 17043297
    [Abstract] [Full Text] [Related]

  • 9. Cerebrospinal fluid markers in neurological disorders.
    Massaro AR, Scivoletto G, Tonali P.
    Ital J Neurol Sci; 1990 Dec 15; 11(6):537-47. PubMed ID: 1707039
    [Abstract] [Full Text] [Related]

  • 10. Serum- and CSF-concentrations of brain specific proteins in hydrocephalus.
    Beems T, Simons KS, Van Geel WJ, De Reus HP, Vos PE, Verbeek MM.
    Acta Neurochir (Wien); 2003 Jan 15; 145(1):37-43. PubMed ID: 12545260
    [Abstract] [Full Text] [Related]

  • 11. Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases.
    Mokuno K, Kato K, Kawai K, Matsuoka Y, Yanagi T, Sobue I.
    J Neurol Sci; 1983 Jan 15; 60(3):443-51. PubMed ID: 6355398
    [Abstract] [Full Text] [Related]

  • 12. Neuron-specific enolase and myelin basic protein: relationship of cerebrospinal fluid concentrations to the neurologic condition of asphyxiated full-term infants.
    Garcia-Alix A, Cabañas F, Pellicer A, Hernanz A, Stiris TA, Quero J.
    Pediatrics; 1994 Feb 15; 93(2):234-40. PubMed ID: 7510064
    [Abstract] [Full Text] [Related]

  • 13. [Level of S-100 and neuron-specific enolase in cerebrospinal fluid from subjects with neurological pathologies].
    Infante JR, Martínez A, Ochoa J, Cañadillas F, Torres-Avisbal M, Vallejo JA, González FM, Pacheco C, Latre JM.
    Rev Esp Med Nucl; 2003 Feb 15; 22(4):238-43. PubMed ID: 12846948
    [Abstract] [Full Text] [Related]

  • 14. [Cerebrospinal fluid level of aldolase C in patients with various neurological disorders: comparison with neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme].
    Murayama T, Matsuoka Y, Takahashi A, Kato K, Yanagi T.
    Rinsho Shinkeigaku; 1989 May 15; 29(5):568-73. PubMed ID: 2791404
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Cerebrospinal fluid neuron-specific enolase in non-selected patients.
    Finsterer J, Exner M, Rumpold H.
    Scand J Clin Lab Invest; 2004 May 15; 64(6):553-8. PubMed ID: 15370460
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Central nervous system disorders in myotonic dystrophy--with special reference to neuron-specific enolase, S-100b protein and creatine kinase BB isoenzyme levels in CSF].
    Yoneyama S, Mokuno K, Matsuoka Y, Takahashi A, Kato K.
    Rinsho Shinkeigaku; 1992 Jun 15; 32(6):572-6. PubMed ID: 1424333
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.